Catheter Precision, Inc. (VTAK) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US74933X7084
Catheter Precision, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 819,000.00 USD |
| Gross profit | 756,000.00 USD |
| Operating income | -21.14 m USD |
| EBIT | -19.54 m USD |
| Net income | -17.18 m USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Catheter Precision, Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
More stocks
- Adagio Medical Holdings, Inc. (ADGM)
- GPO Plus, Inc. (GPOX)
- Ocean Thermal Energy Corp (CPWR)
- Sirius Media (ALSRS.PA)
- Odyssey Health, Inc. (ODYY)
- AVENUE THERAPEUTICS, INC. (ATXI)
- Lunai Bioworks Inc. (LNAI)
- Mentor Capital, Inc. (MNTR)
- ProtoKinetix, Inc. (PKTX)
- Athena Bitcoin Global (ABIT)
- Protagenic Therapeutics, Inc.\new (PTIX)
- Everything Blockchain, Inc. (EBZT)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.